3r7x
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | [[Image:3r7x.jpg|left|200px]] | |
- | The | + | <!-- |
+ | The line below this paragraph, containing "STRUCTURE_3r7x", creates the "Structure Box" on the page. | ||
+ | You may change the PDB parameter (which sets the PDB file loaded into the applet) | ||
+ | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | ||
+ | or leave the SCENE parameter empty for the default display. | ||
+ | --> | ||
+ | {{STRUCTURE_3r7x| PDB=3r7x | SCENE= }} | ||
- | + | ===Crystal Structure Analysis of a Quinazolinedione sulfonamide bound to human GluR2: A Novel Class of Competitive AMPA Receptor Antagonists with Oral Activity=== | |
- | + | ||
+ | <!-- | ||
+ | The line below this paragraph, {{ABSTRACT_PUBMED_21531559}}, adds the Publication Abstract to the page | ||
+ | (as it appears on PubMed at http://www.pubmed.gov), where 21531559 is the PubMed ID number. | ||
+ | --> | ||
+ | {{ABSTRACT_PUBMED_21531559}} | ||
+ | |||
+ | ==About this Structure== | ||
+ | [[3r7x]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3R7X OCA]. | ||
+ | |||
+ | ==Reference== | ||
+ | <ref group="xtra">PMID:021531559</ref><references group="xtra"/> | ||
+ | [[Category: Homo sapiens]] | ||
+ | [[Category: Kallen, J.]] |
Revision as of 05:33, 18 May 2011
Crystal Structure Analysis of a Quinazolinedione sulfonamide bound to human GluR2: A Novel Class of Competitive AMPA Receptor Antagonists with Oral Activity
Template:ABSTRACT PUBMED 21531559
About this Structure
3r7x is a 2 chain structure with sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Koller M, Lingenhoehl K, Schmutz M, Vranesic IT, Kallen J, Auberson YP, Carcache DA, Mattes H, Ofner S, Orain D, Urwyler S. Quinazolinedione sulfonamides: A novel class of competitive AMPA receptor antagonists with oral activity. Bioorg Med Chem Lett. 2011 Apr 8. PMID:21531559 doi:10.1016/j.bmcl.2011.04.017